Regeneron Pharmaceuticals, Inc. (LON:0R2M)
546.04
-2.27 (-0.41%)
At close: Aug 1, 2025
Regeneron Pharmaceuticals Employees
Regeneron Pharmaceuticals had 15,106 employees as of December 31, 2024. The number of employees increased by 1,656 or 12.31% compared to the previous year.
Employees
15,106
Change (1Y)
1,656
Growth (1Y)
12.31%
Revenue / Employee
$684,453
Profits / Employee
$214,694
Market Cap
43.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 15,106 | 1,656 | 12.31% |
Dec 31, 2023 | 13,450 | 1,599 | 13.49% |
Dec 31, 2022 | 11,851 | 1,483 | 14.30% |
Dec 31, 2021 | 10,368 | 1,245 | 13.65% |
Dec 31, 2020 | 9,123 | 1,023 | 12.63% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
HUTCHMED (China) | 1,811 |
Oxford Nanopore Technologies | 1,382 |
Regeneron Pharmaceuticals News
- 3 days ago - 5 Stocks That Launched New Dividends In This Roller-Coaster Market - Forbes
- 8 days ago - Regeneron Announces the 2025 Winners of the Regeneron Prize for Creative Innovation - GlobeNewsWire
- 9 days ago - ANI Pharma drops as clinical trial for eye implant fails against Regeneron’s Eylea - Seeking Alpha
- 21 days ago - SA analyst upgrades/downgrades: CVX, TLRY, LULU, REGN - Seeking Alpha
- 22 days ago - Regeneron Pharmaceuticals: My Highest Conviction Pharma Pick For 2025 - Seeking Alpha
- 23 days ago - Merck Strikes $10-Billion Deal For Verona, Secures First-In-Class COPD Drug - Benzinga
- 4 weeks ago - Regeneron Gets Accelerated FDA OK of Lynozyfic for Blood Cancer Treatment - WSJ
- 4 weeks ago - Regeneron wins FDA accelerated nod for multiple myeloma therapy - Seeking Alpha